Items where authors include "Evgin, L"

Article

Kottke, T, Tonne, J, Evgin, L et al. (19 more authors) (2021) Oncolytic virotherapy induced CSDE1 neo-antigenesis restricts VSV replication but can be targeted by immunotherapy. Nature Communications, 12 (1). 1930. ISSN 2041-1723

Driscoll, CB, Schuelke, MR, Kottke, T et al. (17 more authors) (2020) APOBEC3B-mediated Corruption of the Tumor Cell Immunopeptidome Induces Heteroclitic Neoepitopes for Cancer Immunotherapy. Nature Communications, 11. 790. ISSN 2041-1723

Schuelke, MR, Wongthida, P, Thompson, J et al. (8 more authors) (2019) Diverse immunotherapies can effectively treat syngeneic brainstem tumors in the absence of overt toxicity. Journal for ImmunoTherapy of Cancer, 7 (1). 188. ISSN 2051-1426

Huff, AL, Wongthida, P, Kottke, T et al. (12 more authors) (2018) APOBEC3 Mediates Resistance to Oncolytic Viral Therapy. Molecular Therapy - Oncolytics, 11. pp. 1-13.

Forbes, NS, Coffin, RS, Deng, L et al. (20 more authors) (2018) White paper on microbial anti-cancer therapy and prevention. Journal for ImmunoTherapy of Cancer, 6 (1). ARTN 78. ISSN 2051-1426

Kottke, T, Evgin, L, Shim, KG et al. (12 more authors) (2017) Subversion of NK-cell and TNFα Immune Surveillance Drives Tumor Recurrence. Cancer Immunology Research, 5 (11). pp. 1029-1045. ISSN 2326-6066

Shim, KG, Zaidi, S, Thompson, J et al. (8 more authors) (2017) Inhibitory Receptors Induced by VSV Viroimmunotherapy Are Not Necessarily Targets for Improving Treatment Efficacy. Molecular Therapy, 25 (4). pp. 962-975. ISSN 1525-0016

Ilett, E, Kottke, T, Thompson, J et al. (12 more authors) (2017) Prime-boost using separate oncolytic viruses in combination with checkpoint blockade improves anti-tumor therapy. Gene Therapy, 24 (1). pp. 21-30. ISSN 0969-7128

Kottke, T, Shim, KG, Alonso-Camino, V et al. (12 more authors) (2016) Immunogenicity of self tumor associated proteins is enhanced through protein truncation. Molecular Therapy - Oncolytics, 3. 16030.

Proceedings Paper

Schuelke, M, Evgin, L, Kottke, T et al. (8 more authors) (2016) Balancing Anti-Tumor Efficacy with Local Inflammatory Toxicity for the Treatment of Diffuse Intrinsic Pontine Glioma and Other Brain Tumors. In: Molecular Therapy. 19th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT), 04-07 May 2016, Washington DC, USA. Nature Publishing Group , S77-S77.

Kottke, T, Shim, KG, Evgin, L et al. (13 more authors) (2016) Immunogenicity of Self Tumor Associated Antigens Is Enhanced Through Protein Truncation. In: Molecular Therapy. 19th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT), 04-07 May 2016, Washington DC, USA. Nature Publishing Group , S28-S28.